[The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].

Authors: Golovics PA,Lakatos PL,Dávid G,Pandur T,Erdélyi Z,Horváth A,Mester G,Balogh M,Szipocs I,Molnár C,Komáromi E,Lovász BD,Szathmári M,Kiss LS,Lakatos L,
Address: Semmelweis Egyetem, Általános Orvostudományi Kar I. Belgyógyászati Klinika Budapest Korányi S. u. 2/A 1083.
Journal: Orv Hetil.


Publication: 2012 Apr 8;153(14):541-52. doi: 10.1556/OH.2012.29331.

abstract

Medical therapy for Crohn's disease has changed significantly over the past 20 years with the increasing use of immunosuppressants. In contrast, surgery rates are still high and evidence about the the changes in the outcome of Crohn's disease over the past decades is scarce.

AIMS:

The objective of this study was to analyze the evolution of the surgical rates and medical therapy in the population-based Veszprém county database.

METHODS:

Data of 506 Crohn's disease patients were analyzed (age at diagnosis: 31.5 years, SD: 13.8 years). Both hospital and outpatient records were collected and comprehensively reviewed. The study population was divided into three groups based on the year of diagnosis (cohort A: 1977-1989, cohort B: 1990-1998 and cohort C: 1999-2008).

RESULTS:

Overall azathioprine, systemic steroid, and biological (only available after 1998) exposure was 45.8, 68.6, and 9.5%, respectively. The 1 and 5-year probabilities of azathioprine use were 3.2 and 6.2% in cohort A, 11.4 and 29.9% in cohort B, and 34.8 and 46.2% in cohort C. In multivariate analysis, decade of diagnosis (P<0.001), age at onset (P = 0.008), disease behavior at diagnosis (P<0.001), and need for systemic steroids (P<0.001) were significantly associated with the time to initiation of azathioprine therapy. early azathioprine use was significantly associated with the time to intestinal surgery in Crohn's disease patients; in a multivariate Cox analysis (HR: 0.43, 95% confidence interval (CI): 0.28-0.65) and after matching on propensity scores for azathioprine use (HR: 0.42,95% CI:0.26-0.67).

CONCLUSIONS:

This population-based inception cohort showed that reduction in surgical rates was independently associated with increased and earlier azathioprine use.



Related Articles
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
Am J Gastroenterol. 2012
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, et al. Am J Gastroenterol. 2012 Apr; 107(4):579-88. Epub 2012 Jan 10.
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
Gut. 2010
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Gut. 2010 Sep; 59(9):1200-6. Epub 2010 Jul 21.
Natural history of pediatric Crohn's disease: a population-based cohort study.
Gastroenterology. 2008
Natural history of pediatric Crohn's disease: a population-based cohort study.
Vernier-Massouille G, Balde M, Salleron J, Turck D, Dupas JL, Mouterde O, Merle V, Salomez JL, Branche J, Marti R, et al. Gastroenterology. 2008 Oct; 135(4):1106-13. Epub 2008 Jul 3.
Review Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Cochrane Database Syst Rev. 2009
Review Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Prefontaine E, Macdonald JK, Sutherland LR. Cochrane Database Syst Rev. 2009 Oct 7; (4):CD000545. Epub 2009 Oct 7.
Review Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Cochrane Database Syst Rev. 2010
Review Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Prefontaine E, Macdonald JK, Sutherland LR. Cochrane Database Syst Rev. 2010 Jun 16; (6):CD000545. Epub 2010 Jun 16.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.